ovarian%20mass
OVARIAN MASS
Ovarian cysts are typically noted after clinical screening, or as a result of exam for a suspected pelvic mass, or an incidental finding in investigations done for other reasons.
Most ovarian masses manifest with few or mild nonspecific symptoms.
Ovarian masses in women of reproductive age are mostly benign but the risk of malignancy increases with age.
Ovarian cysts in the prepubertal patients especially after the first week of life are abnormal and likely to be neoplastic. In adolescent patients, majority of ovarian masses are functional cysts.

Introduction

  • Ovarian cysts in prepubertal patients especially after the first week of life are abnormal and likely to be neoplastic, prompt ultrasound (US) evaluation and referral are warranted 
  • In adolescent patients, majority of ovarian masses are functional cysts
    • The most common neoplastic ovarian tumor in this age group is benign cystic teratoma of the ovary
  • Ovarian mass in women of reproductive age is mostly benign but the risk of malignancy increases with age
    • In most adnexal masses, malignancy is found in only 7-13% of premenopausal and 8-45% of postmenopausal patients
    • Risk of malignancy for ovarian tumor in patients <45 years is <1 in 15 while in postmenopausal women, the figure is 50% at the time of laparotomy 

Signs and Symptoms

  • Most ovarian masses manifest with few or mild nonspecific symptoms
    • Common symptoms include abdominal distension, abdominal pain or discomfort, metrorrhagia, dyspareunia, infertility, lower abdominal pressure sensation and urinary or gastrointestinal (GI) symptoms
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Roshini Claire Anthony, 4 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

07 Jun 2019
Low-dose aspirin therapy does not confer significant benefits to elderly patients with hypertension, but treatment appears to increase the risk of haemorrhagic events, suggest a Japan study.
4 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.